| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: A non-randomised pilot study
|
|
|
1991
|
7 |
4 |
p. 272-
1 p.
|
article
|
| 2 |
A compartment model of carcinogenesis in lung cancer
|
|
|
1991
|
7 |
4 |
p. 262-
1 p.
|
article
|
| 3 |
Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma: A 5-year survival analysis
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 4 |
Adjuvant thoracic radiotherapy in small cell lung cancer: ten-year follow-up of a randomized study
|
Rosenthal, M.A.
|
|
1991
|
7 |
4 |
p. 235-241
7 p.
|
article
|
| 5 |
An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule
|
|
|
1991
|
7 |
4 |
p. 264-
1 p.
|
article
|
| 6 |
A novel alteration in the epidermal growth factor receptor gene is frequently detected in human non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 7 |
Antibiotic prophylaxis in lung cancer surgery
|
|
|
1991
|
7 |
4 |
p. 270-
1 p.
|
article
|
| 8 |
APACHE II in surgical lung carcinoma patients
|
|
|
1991
|
7 |
4 |
p. 270-
1 p.
|
article
|
| 9 |
A phase II study evaluating CA Vi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 273-
1 p.
|
article
|
| 10 |
A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 271-
1 p.
|
article
|
| 11 |
A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 12 |
Bronchial carcinoma associated with pulmonary osteoarthropathy (Marie Bamberger disease)
|
|
|
1991
|
7 |
4 |
p. 268-
1 p.
|
article
|
| 13 |
Bronchial neuroendocrine (Carcinoid) tumor causing unilateral left-sided carcinoid heart disease
|
|
|
1991
|
7 |
4 |
p. 267-
1 p.
|
article
|
| 14 |
Cancer risk among glass factory workers: An excess of lung cancer?
|
|
|
1991
|
7 |
4 |
p. 262-
1 p.
|
article
|
| 15 |
Carboplatin and etoposide in advanced lung cancer: — A phase I study
|
|
|
1991
|
7 |
4 |
p. 273-
1 p.
|
article
|
| 16 |
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 17 |
Case-control study of residential radon and lung cancer among New Jersey women
|
|
|
1991
|
7 |
4 |
p. 262-
1 p.
|
article
|
| 18 |
CCK-antagonists interact with CCK-B receptors on human small cell lung cancer cells
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 19 |
Cell-surface antigens of human lung tumors detected by mouse monoclonal antibodies: Definition of blood-group- and non-blood-group-related antigenic systems
|
|
|
1991
|
7 |
4 |
p. 264-
1 p.
|
article
|
| 20 |
Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines
|
|
|
1991
|
7 |
4 |
p. 264-
1 p.
|
article
|
| 21 |
Chemosensitivity testing of small cell lung cancer using the MTT assay
|
|
|
1991
|
7 |
4 |
p. 272-
1 p.
|
article
|
| 22 |
Chemotherapy in advanced non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 278-
1 p.
|
article
|
| 23 |
Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature
|
Donnadieu, N.
|
|
1991
|
7 |
4 |
p. 243-252
10 p.
|
article
|
| 24 |
Chemotherapy or not in advanced non-small cell lung cancer?
|
|
|
1991
|
7 |
4 |
p. 273-274
2 p.
|
article
|
| 25 |
Circadian tolerance to etoposide and cisplatin as first line treatment for advanced lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 26 |
Circulating hematopoietic progenitors in patients with primary lung cancer
|
|
|
1991
|
7 |
4 |
p. 272-
1 p.
|
article
|
| 27 |
Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patients
|
|
|
1991
|
7 |
4 |
p. 274-
1 p.
|
article
|
| 28 |
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: A cancer and leukemia group B study
|
|
|
1991
|
7 |
4 |
p. 271-
1 p.
|
article
|
| 29 |
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens
|
|
|
1991
|
7 |
4 |
p. 271-272
2 p.
|
article
|
| 30 |
Combined modality therapy for locally advanced non-small cell lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 31 |
Comparison of epidermal growth factor receptor expression in lung cancer by immunohistochemical staining of both frozen and formalin fixed specimens
|
|
|
1991
|
7 |
4 |
p. 263-
1 p.
|
article
|
| 32 |
Congenital tracheoesophageal fistula associated with carcinoma of the lung in an adult
|
|
|
1991
|
7 |
4 |
p. 268-
1 p.
|
article
|
| 33 |
Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival
|
|
|
1991
|
7 |
4 |
p. 270-
1 p.
|
article
|
| 34 |
Crystalline silica and lung cancer: A review of recent experimental evidence
|
|
|
1991
|
7 |
4 |
p. 261-
1 p.
|
article
|
| 35 |
Current status of etoposide in the management of small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 271-
1 p.
|
article
|
| 36 |
Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: A meta-analytic review
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 37 |
Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients
|
|
|
1991
|
7 |
4 |
p. 263-
1 p.
|
article
|
| 38 |
Differential diagnosis of lung tumor with positron emission tomography: A prospective study
|
|
|
1991
|
7 |
4 |
p. 268-
1 p.
|
article
|
| 39 |
Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines
|
|
|
1991
|
7 |
4 |
p. 263-
1 p.
|
article
|
| 40 |
Drug delivery strategies in malignant disease of the lung
|
|
|
1991
|
7 |
4 |
p. 276-
1 p.
|
article
|
| 41 |
Echocardiography in the initial assessment of patients with small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 42 |
Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 43 |
Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 44 |
Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 267-268
2 p.
|
article
|
| 45 |
4′-Epi-doxorubicin in advanced lung cancer. A phase II trial
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 46 |
Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: Characterization and mechanism of resistance
|
|
|
1991
|
7 |
4 |
p. 276-
1 p.
|
article
|
| 47 |
Estimation of risk of surgery of lung cancer by means of quantitative perfusion scintigraphy
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 48 |
Estrogen and progesterone receptors in bronchogenic carcinoma
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 49 |
Etoposide in the management of non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 271-
1 p.
|
article
|
| 50 |
Evaluation of serum CA 125 as a tumor marker in non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 267-
1 p.
|
article
|
| 51 |
Experimental lung carcinogenesis. An overview on present work and future needs
|
|
|
1991
|
7 |
4 |
p. 278-
1 p.
|
article
|
| 52 |
Experimental models of regional chemotherapy via the pulmonary artery using cisplatin
|
|
|
1991
|
7 |
4 |
p. 272-
1 p.
|
article
|
| 53 |
Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 274-
1 p.
|
article
|
| 54 |
Gene amplification in human lung cancer: The myc family genes and other proto-oncogenes and growth factor genes
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 55 |
Ha-ras-1 alleles in Norwegian lung cancer patients
|
|
|
1991
|
7 |
4 |
p. 263-
1 p.
|
article
|
| 56 |
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: A phase II study of the Northern California Oncology Group
|
|
|
1991
|
7 |
4 |
p. 273-
1 p.
|
article
|
| 57 |
How valuable is response as prognostic criterium in non-small cell lung cancer?
|
Sørensen, J.B.
|
|
1991
|
7 |
4 |
p. 253-257
5 p.
|
article
|
| 58 |
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 272-273
2 p.
|
article
|
| 59 |
Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigen
|
|
|
1991
|
7 |
4 |
p. 268-
1 p.
|
article
|
| 60 |
Immune reactivity in bronchogenic carcinoma and its relation to 5-year survival rate
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 61 |
Immunocytochemical characterization of lung tumors in fine-needle aspiration. The use of cytokeratin monoclonal antibodies for the differential diagnosis of squamous cell carcinoma and adenocarcinoma
|
|
|
1991
|
7 |
4 |
p. 267-
1 p.
|
article
|
| 62 |
Inactivation of the retinoblastoma gene in a human lung carcinoma cell line detected by single-strand conformation polymorphism analysis of the polymerase chain reaction product of cDNA
|
|
|
1991
|
7 |
4 |
p. 263-
1 p.
|
article
|
| 63 |
Increased risk of lung cancer in the melting department of a second Ontario steel manufacturer
|
|
|
1991
|
7 |
4 |
p. 261-
1 p.
|
article
|
| 64 |
Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells
|
|
|
1991
|
7 |
4 |
p. 262-
1 p.
|
article
|
| 65 |
In vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 66 |
Long-term results of operation for non-small cell lung cancer in the elderly
|
|
|
1991
|
7 |
4 |
p. 269-270
2 p.
|
article
|
| 67 |
Lung cancer at Groote Schuur Hospital — a local perspective
|
|
|
1991
|
7 |
4 |
p. 278-
1 p.
|
article
|
| 68 |
Lung cancer chronicles
|
|
|
1991
|
7 |
4 |
p. 259-260
2 p.
|
article
|
| 69 |
Modulation of p53 gene expression and cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 70 |
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 71 |
Nd-YAG laser resection and ‘endoxane’ endobronchial prosthesis in the palliative treatment of tracheobronchial malignant tumors
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 72 |
Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 270-
1 p.
|
article
|
| 73 |
Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 276-
1 p.
|
article
|
| 74 |
Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 276-
1 p.
|
article
|
| 75 |
Phase II study of high-dose epirubicin in non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 270-271
2 p.
|
article
|
| 76 |
Phase I study of acivicin and cisplatin in non-small-cell lung cancer: A National Cancer Institute of Canada study
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 77 |
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma
|
|
|
1991
|
7 |
4 |
p. 275-276
2 p.
|
article
|
| 78 |
Potential lung cancer risk from indoor radon exposure
|
|
|
1991
|
7 |
4 |
p. 261-
1 p.
|
article
|
| 79 |
Primary pedunculated leiomyosarcoma of the lung
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 80 |
Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit
|
|
|
1991
|
7 |
4 |
p. 267-
1 p.
|
article
|
| 81 |
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: A phase II trial
|
|
|
1991
|
7 |
4 |
p. 276-
1 p.
|
article
|
| 82 |
Radiosensitivity of different human tumor lines grown as xenografts determined from growth delay and survival data
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 83 |
Recent advances in etoposide therapy for non-small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 271-
1 p.
|
article
|
| 84 |
Recessive oncogenes in lung cancer
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 85 |
Recurrent chromosome aberrations in human lung squamous cell carcinomas
|
|
|
1991
|
7 |
4 |
p. 266-
1 p.
|
article
|
| 86 |
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts
|
|
|
1991
|
7 |
4 |
p. 275-
1 p.
|
article
|
| 87 |
184Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice
|
|
|
1991
|
7 |
4 |
p. 263-264
2 p.
|
article
|
| 88 |
Screening for lung cancer. A critique of the Mayo Lung Project
|
|
|
1991
|
7 |
4 |
p. 261-
1 p.
|
article
|
| 89 |
Serum CA125 level is a good prognostic indicator in lung cancer
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 90 |
Small cell lung cancer antigen expression differs on ‘classic’ and ‘variant’ SCLC and carcinoid cells
|
Koros, Aurelia M.C.
|
|
1991
|
7 |
4 |
p. 225-234
10 p.
|
article
|
| 91 |
Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas
|
|
|
1991
|
7 |
4 |
p. 261-262
2 p.
|
article
|
| 92 |
src Expression in small-cell lung carcinoma and other neuroendocrine malignancies
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 93 |
Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin
|
|
|
1991
|
7 |
4 |
p. 273-
1 p.
|
article
|
| 94 |
Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer
|
|
|
1991
|
7 |
4 |
p. 274-
1 p.
|
article
|
| 95 |
Surgical approach to non-small cell lung cancer stage I and II
|
|
|
1991
|
7 |
4 |
p. 269-
1 p.
|
article
|
| 96 |
Symptomatic pericardial effusion in lung cancer patients: The role of fluid cytology
|
|
|
1991
|
7 |
4 |
p. 268-269
2 p.
|
article
|
| 97 |
Taste thresholds in patients with small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 267-
1 p.
|
article
|
| 98 |
TCNU in adenocarcinoma of the lung: A phase II study with divided doses
|
|
|
1991
|
7 |
4 |
p. 274-
1 p.
|
article
|
| 99 |
The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: Interleukin 3 enhances the proliferation in one of the eleven cell lines
|
|
|
1991
|
7 |
4 |
p. 264-
1 p.
|
article
|
| 100 |
The radiation response of a human lung adenocarcinoma grown in monolayer, as spheroids, and in nude mice
|
Schwachöfer, J.H.M.
|
|
1991
|
7 |
4 |
p. 213-223
11 p.
|
article
|
| 101 |
The ras oncogenes in human lung cancer
|
|
|
1991
|
7 |
4 |
p. 265-
1 p.
|
article
|
| 102 |
The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 268-
1 p.
|
article
|
| 103 |
The role of surgery in small cell lung cancer
|
|
|
1991
|
7 |
4 |
p. 270-
1 p.
|
article
|
| 104 |
The superior vena cava syndrome as energy case in radiotherapy
|
|
|
1991
|
7 |
4 |
p. 277-
1 p.
|
article
|
| 105 |
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: A southwest oncology group pilot study
|
|
|
1991
|
7 |
4 |
p. 274-
1 p.
|
article
|
| 106 |
Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients
|
|
|
1991
|
7 |
4 |
p. 273-
1 p.
|
article
|
| 107 |
Urban-rural differences in lung cancer occurrence. Time trends in Jews in Israel
|
|
|
1991
|
7 |
4 |
p. 262-
1 p.
|
article
|
| 108 |
Use of “time windows” to investigate lung cancer latency intervals at an Ontario steel plant
|
|
|
1991
|
7 |
4 |
p. 261-
1 p.
|
article
|
| 109 |
Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels
|
|
|
1991
|
7 |
4 |
p. 264-
1 p.
|
article
|
Journal description